Literature DB >> 20507750

Vaccinia virus infection in monkeys, Brazilian Amazon.

Jônatas S Abrahão1, André T Silva-Fernandes, Larissa S Lima, Rafael K Campos, Maria I M C Guedes, Marcela M G Cota, Felipe L Assis, Iara A Borges, Milton F Souza-Júnior, Zélia I P Lobato, Cláudio A Bonjardim, Paulo C P Ferreira, Giliane S Trindade, Erna G Kroon.   

Abstract

To detect orthopoxvirus in the Brazilian Amazon, we conducted a serosurvey of 344 wild animals. Neutralizing antibodies against orthopoxvirus were detected by plaque-reduction neutralizing tests in 84 serum samples. Amplicons from 6 monkey samples were sequenced. These amplicons identified vaccinia virus genetically similar to strains from bovine vaccinia outbreaks in Brazil.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20507750      PMCID: PMC3086250          DOI: 10.3201/eid1606.091187

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


In Brazil, several exanthematic vaccinia virus (VACV) outbreaks affecting dairy cattle and rural workers have been reported since 1999 (,). VACV, the prototype of the genus Orthopoxvirus, shows serologic cross-reactivity with other Orthopoxvirus species and was used during the smallpox eradication campaign (). Bovine vaccinia causes economic losses and affects public health services in Brazil (). VACV reservoirs and the role of wildlife in outbreaks remain unidentified. Although some data indicate that VACV strains circulate in rodents in forests in Brazil (,), there is no evidence of VACV infection in other wild mammals. To detect orthopoxviruses in the Brazilian Amazon, we conducted a serosurvey of wild animals in this region. We detected antibodies against orthopoxviruses in 4 mammalian species. Using molecular methods, we confirmed exposure of monkeys to VACV. Although our findings are uncertain in the context of bovine vaccinia outbreaks, we provide new biologic and epidemiologic information about VACV.

The Study

During February 2001–September 2002, we captured 344 wild mammals in an overflow area in a fauna-rescue program during construction of a hydroelectric plant in Lajeado and Ipueiras counties (9°44′58′′S, 48°21′23′′W) in Tocantins State, Brazil. During this program, 269 capuchin monkeys (Cebus apella), 27 black-howling monkeys (Allouata caraya), 12 coatis (Nasua nasua), 20 agoutis (Dasyprocta sp.), 2 opossums (Didelphis albiventris), 5 armadillos (Euphractus sexcinctus), 5 collared anteaters (Tamandua tetradactila), and 4 gray foxes (Cerdocyon thous) were captured. All animals were captured in a sylvatic area and did not have contact with humans and dairy cattle. In field-screening laboratories, animals were sedated, serum samples were collected, and veterinary evaluations were made. Animals were then released in areas selected during environmental conservation programs. Until 2002, bovine vaccinia had been restricted to southeastern Brazil, >1,400 km from the study area (). Serum samples were inactivated by heating at 56°C for 30 min, and an orthopoxvirus plaque-reduction neutralizing test (PRNT) was performed. PRNT was used rather than ELISA because secondary antibodies required for an ELISA for all analyzed species were unavailable. Inactivated samples were diluted 1:20×–1:1,640× in minimal essential medium and tested in Vero cells by using the VACV-Western Reserve strain in the PRNT as described (). Human samples positive for antibodies to orthopoxvirus obtained during bovine vaccinia outbreaks were used as positive controls (); samples negative for these antibodies were used as negative controls (). Serum titer was defined as the highest dilution that inhibited >50% of viral plaques compared with negative controls. Orthopoxvirus PRNT specificity (97.4%) and sensitivity (93.5%) were confirmed by using receiver-operating characteristic analysis, which compared results of PRNT, ELISA, and clinical symptoms during bovine vaccinia outbreaks (,). PRNT showed a high prevalence of seropositive monkeys (Table). Of 269 C. apella samples, 68 (25.3%) had antibodies to orthopoxvirus. Of 27 A. caraya samples, 13 (48.1%) had antibodies to orthopoxvirus. Seropositivity was detected in 2 (16.6%) coatis and 1 (5.0%) agouti. Antibodies to orthopoxvirus were not detected in any other species tested. Of 344 animals studied, 84 (24.4%) had antibodies to orthopoxvirus (Table). In samples with high neutralizing antibody titers, 55.95% (47) had titers of 80–320. Only 5 (6.0%) PRNT-positive samples had titers <40 (Table).
Table

Seroprevalence of vaccinia virus in monkeys, Brazilian Amazon*

SpeciesNo. serum samples testedPRNT titer, no. positive
Total no. (%)No. (%) PCR positive
204080160320
Cebus apella 269224364268 (25.3)11 (4.1)
Allouata caraya 273550013 (48.1)7 (25.9)
Nasua nasua 12020002 (16.6)0
Dasyprocta sp.20010001 (5.0)0
Didelphis albiventris 20000000
Euphractus sexcinctus 50000000
Tamandua tetradactila 50000000
Cerdocyon thous
4
0
0
0
0
0
0
0
Total344532414284 (24.4)18 (5.2)

*PRNT, plaque-reduction neutralization test.

*PRNT, plaque-reduction neutralization test. Given the serologic cross-reactivity of orthopoxvirus (), positive samples could indicate any of >9 virus species, although it is well established that VACV is endemic to Brazil, and infections with other orthopoxviruses are geographically restricted to other continents and have not been identified in Brazil. Therefore, we performed a molecular investigation to identify orthopoxviruses associated with orthopoxvirus sylvatic circulation. Serologic and molecular tests were performed in a blinded fashion and in triplicate. On the basis of previous studies that detected orthopoxvirus DNA in serum of infected hosts (,,), a semi-nested PCR was used to amplify the highly conserved orthopoxvirus vaccinia growth factor (vgf) gene (J.S. Abrahão et al., unpub.data) from mammal serum samples. Human VACV DNA–positive and DNA–negative serum samples obtained during bovine vaccinia outbreaks () were used as positive and negative controls, respectively. Field and laboratory clinical samples were processed separately to avoid cross-contamination. Eighteen of 344 serum samples were positive in PCR assays (11 from C. apella and 7 from A. caraya; all were PRNT positive). Six of the 18 vgf PCR-positive samples were chosen for sequencing and analysis of vgf (4 from C. apella and 2 from A. caraya). In addition, using primers described by Ropp et al. (), we amplified the hemagglutinin (ha) gene from 2 samples (1 from C. apella and 1 from A. caraya; both were vgf positive). The vgf and ha PCR products were cloned into the pGEMT-easy vector (Promega, Madison, WI, USA). Three clones from distinct PCR amplicons of each sample were sequenced in both orientations by using M13 universal primers and the Mega-BACE-sequencer (GE Healthcare, Little Chalfont, UK). Optimal alignment of the highly conserved vgf gene with ClustalW (www.ncbi.nlm.nih.gov/pmc/articles/PMC308517) and MEGA version 3.1 (www.megasoftware.net) showed 100% identity among all nucleotide and amino acid sequences for monkey serum (Appendix Figure, panel A). When compared with nucleotide sequences available in GenBank, vgf sequences were highly similar (98%–100% identity) to the homologous gene from other VACV strains and showed 100% identity. The ha sequences for C. apella and A. caraya showed a signature deletion (Appendix Figure, panel B) also present in sequences of other VACV isolates from Brazil. These ha sequences showed 99.6% identity at the nucleotide level and 99.7% identity at the amino acid level (736 nt of the ha gene were analyzed). Phylogenetic trees of the vgf (Figure, panel A) or ha (Figure, panel B) genes were constructed by using the neighbor-joining method, 1,000 bootstrap replicates, and the Tamura 3-parameter model (MEGA version 3.1). These sylvatic VACV sequences clustered with several VACVs isolated during several bovine vaccinia outbreaks. The vgf and ha sequences from monkey samples were deposited in GenBank (accession nos. VACV-TO vgf GQ465372 and GQ465373 and ha GU322359 and GU322360). Orthopoxvirus DNA was not detected in any other species tested.
Figure

Consensus bootstrap phylogenetic trees based on nucleotide sequences of orthopoxvirus vaccinia growth factor (vgf) (A) and hemagglutinin (ha) (B) genes. Trees were constructed with ha or vgf sequences by using the neighbor-joining method with 1,000 bootstrap replicates and the Tamura 3-parameter model in MEGA version 3.1 software (www.megasoftware.net). Bootstrap values >40% are shown. Nucleotide sequences were obtained from GenBank. Black dots indicate vaccinia virus (VACV) obtained from Cebus apella (VACV-TO CA) and Allouata caraya (VACV AC). All vgf sequences obtained from monkey serum samples showed 100% and are represented as a unique sequence in the vgf tree (VACV TO). HSPV, horsepoxvirus; VARV, variola virus; CPXV, cowpoxvirus; MPXV, monkeypoxvirus.

Consensus bootstrap phylogenetic trees based on nucleotide sequences of orthopoxvirus vaccinia growth factor (vgf) (A) and hemagglutinin (ha) (B) genes. Trees were constructed with ha or vgf sequences by using the neighbor-joining method with 1,000 bootstrap replicates and the Tamura 3-parameter model in MEGA version 3.1 software (www.megasoftware.net). Bootstrap values >40% are shown. Nucleotide sequences were obtained from GenBank. Black dots indicate vaccinia virus (VACV) obtained from Cebus apella (VACV-TO CA) and Allouata caraya (VACV AC). All vgf sequences obtained from monkey serum samples showed 100% and are represented as a unique sequence in the vgf tree (VACV TO). HSPV, horsepoxvirus; VARV, variola virus; CPXV, cowpoxvirus; MPXV, monkeypoxvirus.

Conclusions

Although VACV strains have been isolated from rodents in forests in Brazil (,) (the nearest location, Belém, is 750 km from the study area), we detected VACV in wildlife in the Brazilian Amazon 3 years after reports of exanthematic outbreaks of bovine vaccinia and 40 years after isolation of VACV from forests. Our data provide evidence of high prevalence of orthopoxviruses among capuchin and black-howling monkeys in the Brazilian Amazon. The relationship between infected monkeys and emergence of VACV in rural regions of Brazil is unknown. However, transmission of VACV in northeastern Brazil has been reported, and outbreaks have been reported in Mato Grosso, Pernambuco (www.amep.org.br/pox.doc), Maranhão (E.G. Kroon et al., unpub. data), and Tocantins (), which are in or adjacent to the Brazilian Amazon. Some of these viruses may be related to those isolated in this study because some VACV isolates have the same signature deletion in the ha gene as VACV-TO. Anthropogenic disturbance of the Amazon ecosystem and increases in agricultural and livestock areas increase contact between wildlife and rural populations (). However, the effect of VACV in environments in Brazil that contain wild animals has not been studied. Clinical data for pox lesions in animals tested were not well documented by veterinarians in the study area. Ecologic and public health studies should be designed to evaluate risks for infection with VACV during wildlife conservation efforts and determine whether surveillance systems can predict bovine vaccinia outbreaks by monitoring VACV infection in monkeys and other wild animals.

Appendix Figure

Amino acid sequences of vaccinia virus (VACV) samples and comparison with homologous genes sequences from several orthopoxviruses, Brazil. A) Alignment of vaccinia growth factor gene sequences from 6 monkey serum samples showing 100% identity (horizontal box). VACV-TO_CA, sequence from Cebus apella; VACV-TO_AC, sequence from Allouata caraya; HPXV, horsepoxvirus; CPXV, cowpoxvirus; MPXV, monkeypoxvirus; VARV, variola virus; ECMV, ectromelia virus. B) Alignment of orthopoxvirus hemagglutinin gene amino acid sequences showing the deletion signature region (vertical box) in VACV-TO isolates and several VACV strains isolated during bovine vaccinia outbreaks. Arrow indicates polymorphism site in the hemagglutinin amino acid sequences between VACV-TO_CA and VACV-TO_AC. Alignments were made by using ClustalW (www.ncbi.nlm.nih.gov/pmc/articles/PMC308517) and MEGA version 3.1 software (www.megasoftware.net). HSPV, horsepoxvirus.
  11 in total

1.  COTIA VIRUS: A NEW AGENT ISOLATED FROM SENTINEL MICE IN S AO PAULO, BRAZIL.

Authors:  S LOPESODE; J P LACERDA; I E FONSECA; D P CASTRO; O P FORATTINI; E X RABELLO
Journal:  Am J Trop Med Hyg       Date:  1965-01       Impact factor: 2.345

2.  Detection of vaccinia DNA in the blood following smallpox vaccination.

Authors:  Michael R Savona; Wilfred P Dela Cruz; Morris S Jones; Jennifer A Thornton; Dongxiang Xia; Ted L Hadfield; Patrick J Danaher
Journal:  JAMA       Date:  2006-04-26       Impact factor: 56.272

3.  Modelling conservation in the Amazon basin.

Authors:  Britaldo Silveira Soares-Filho; Daniel Curtis Nepstad; Lisa M Curran; Gustavo Coutinho Cerqueira; Ricardo Alexandrino Garcia; Claudia Azevedo Ramos; Eliane Voll; Alice McDonald; Paul Lefebvre; Peter Schlesinger
Journal:  Nature       Date:  2006-03-23       Impact factor: 49.962

4.  An emergent poxvirus from humans and cattle in Rio de Janeiro State: Cantagalo virus may derive from Brazilian smallpox vaccine.

Authors:  C R Damaso; J J Esposito; R C Condit; N Moussatché
Journal:  Virology       Date:  2000-11-25       Impact factor: 3.616

5.  Araçatuba virus: a vaccinialike virus associated with infection in humans and cattle.

Authors:  Giliane de Souza Trindade; Flávio Guimarães da Fonseca; João Trindade Marques; Maurício Lacerda Nogueira; Luiz Claudio Nogueira Mendes; Alexandre Secorun Borges; Juliana Regina Peiró; Edviges Maristela Pituco; Cláudio Antônio Bonjardim; Paulo César Peregrino Ferreira; Erna Geessien Kroon
Journal:  Emerg Infect Dis       Date:  2003-02       Impact factor: 6.883

6.  PCR strategy for identification and differentiation of small pox and other orthopoxviruses.

Authors:  S L Ropp; Q Jin; J C Knight; R F Massung; J J Esposito
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

7.  Detection of vaccinia virus DNA, but not infectious virus, in the blood of smallpox vaccine recipients.

Authors:  Jeffrey I Cohen; Patricia Hohman; Jeanne C Preuss; Li Li; Steven H Fischer; Daniel P Fedorko
Journal:  Vaccine       Date:  2007-04-18       Impact factor: 3.641

8.  Morphological and molecular characterization of the poxvirus BeAn 58058.

Authors:  F G Fonseca; M C Lanna; M A Campos; E W Kitajima; J N Peres; R R Golgher; P C Ferreira; E G Kroon
Journal:  Arch Virol       Date:  1998       Impact factor: 2.574

9.  Natural human infections with Vaccinia virus during bovine vaccinia outbreaks.

Authors:  André Tavares Silva-Fernandes; Carlos Eurico Pires Ferreira Travassos; Jaqueline Maria Siqueira Ferreira; Jônatas Santos Abrahão; Eliseu Soares de Oliveira Rocha; Flávia Viana-Ferreira; João Rodrigues dos Santos; Cláudio Antônio Bonjardim; Paulo César Peregrino Ferreira; Erna Geessien Kroon
Journal:  J Clin Virol       Date:  2009-02-24       Impact factor: 3.168

10.  Passatempo virus, a vaccinia virus strain, Brazil.

Authors:  Juliana A Leite; Betânia P Drumond; Giliane S Trindade; Zélia I P Lobato; Flávio G da Fonseca; Santos João R dos; Marieta C Madureira; Maria I M C Guedes; Jaqueline M S Ferreira; Cláudio A Bonjardim; Paulo C P Ferreira; Erna G Kroon
Journal:  Emerg Infect Dis       Date:  2005-12       Impact factor: 6.883

View more
  28 in total

1.  Mutations conferring resistance to viral DNA polymerase inhibitors in camelpox virus give different drug-susceptibility profiles in vaccinia virus.

Authors:  Sophie Duraffour; Graciela Andrei; Dimitri Topalis; Marcela Krečmerová; Jean-Marc Crance; Daniel Garin; Robert Snoeck
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

2.  Group 1 Vaccinia virus zoonotic outbreak in Maranhao State, Brazil.

Authors:  Danilo Bretas Oliveira; Felipe Lopes Assis; Paulo Cesar Peregrino Ferreira; Cláudio Antônio Bonjardim; Giliane de Souza Trindade; Erna Geessien Kroon; Jônatas Santos Abrahão
Journal:  Am J Trop Med Hyg       Date:  2013-10-28       Impact factor: 2.345

3.  Susceptibility of Vaccinia virus to chemical disinfectants.

Authors:  Tércia Moreira Ludolfo de Oliveira; Izabelle Silva Rehfeld; Maria Isabel Maldonado Coelho Guedes; Jaqueline Maria Siqueira Ferreira; Erna Geessien Kroon; Zélia Inês Portela Lobato
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

Review 4.  Poxviruses and the evolution of host range and virulence.

Authors:  Sherry L Haller; Chen Peng; Grant McFadden; Stefan Rothenburg
Journal:  Infect Genet Evol       Date:  2013-10-24       Impact factor: 3.342

5.  ENDEMIC ORTHOPOXVIRUS CIRCULATING IN PROCYONIDS IN MEXICO.

Authors:  Nadia F Gallardo-Romero; Nidia Aréchiga-Ceballos; Ginny L Emerson; Flor O Martínez-Martínez; Jeffrey B Doty; Yoshinori J Nakazawa; Emilio Rendón-Franco; Claudia I Muñoz-García; Claudia Villanueva-García; Citlali Ramírez-Cid; Lilia M Gama-Campillo; Fernando Gual-Sill; Álvaro Aguilar-Setién; Darin S Carroll
Journal:  J Wildl Dis       Date:  2016-05-25       Impact factor: 1.535

6.  Serologic evidence of orthopoxvirus infection in buffaloes, Brazil.

Authors:  Felipe Lopes de Assis; Graziele Pereira; Cairo Oliveira; Gisele Olinto Libânio Rodrigues; Marcela Menezas Gomes Cotta; Andre Tavares Silva-Fernandes; Paulo Cesar Peregrino Ferreira; Cláudio Antônio Bonjardim; Giliane de Souza Trindade; Erna Geessien Kroon; Jônatas Santos Abrahão
Journal:  Emerg Infect Dis       Date:  2012-04       Impact factor: 6.883

7.  Whence feral vaccinia?

Authors:  Richard C Condit
Journal:  Emerg Infect Dis       Date:  2010-06       Impact factor: 6.883

8.  Study of camelpox virus pathogenesis in athymic nude mice.

Authors:  Sophie Duraffour; Patrick Matthys; Joost J van den Oord; Tim De Schutter; Tania Mitera; Robert Snoeck; Graciela Andrei
Journal:  PLoS One       Date:  2011-06-28       Impact factor: 3.240

9.  Immune modulation in primary vaccinia virus zoonotic human infections.

Authors:  Juliana Assis Silva Gomes; Fernanda Fortes de Araújo; Giliane de Souza Trindade; Bárbara Resende Quinan; Betânia Paiva Drumond; Jaqueline Maria Siqueira Ferreira; Bruno Eduardo Fernandes Mota; Maurício Lacerda Nogueira; Erna Geessien Kroon; Jônatas Santos Abrahão; Rodrigo Côrrea-Oliveira; Flávio Guimarães da Fonseca
Journal:  Clin Dev Immunol       Date:  2011-12-20

10.  Evaluating anti-Orthopoxvirus antibodies in individuals from Brazilian rural areas prior to the bovine vaccinia era.

Authors:  Poliana de Oliveira Figueiredo; André Tavares da Silva-Fernandes; Bruno Eduardo Fernandes Mota; Galileu Barbosa Costa; Iara Apolinário Borges; Paulo César Peregrino Ferreira; Jônatas Santos Abrahão; Erika Martins Braga; Erna Geessien Kroon; Giliane de Souza Trindade
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-09       Impact factor: 2.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.